体液中的甲基化DNA/RNA作为肺癌的生物标志物
Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer.
作者信息
Lu Yan, Li Shulin/Sl, Zhu Shiguo/Sg, Gong Yabin/Yb, Shi Jun/J, Xu Ling/L
机构信息
No.2 oncology department, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, No.110, Ganhe Rd, Shanghai, China.
MD Anderson Cancer Center, the university of Texas, 1840 Old Spanish Trail, Houston, TX USA.
出版信息
Biol Proced Online. 2017 Mar 17;19:2. doi: 10.1186/s12575-017-0051-8. eCollection 2017.
Abstract
DNA/RNA methylation plays an important role in lung cancer initiation and progression. Liquid biopsy makes use of cells, nucleotides and proteins released from tumor cells into body fluids to help with cancer diagnosis and prognosis. Methylation of circulating tumor DNA (ctDNA) has gained increasing attention as biomarkers for lung cancer. Here we briefly introduce the biological basis and detection method of ctDNA methylation, and review various applications of methylated DNA in body fluids in lung cancer screening, diagnosis, prognosis, monitoring and treatment prediction. We also discuss the emerging role of RNA methylation as biomarkers for cancer.
摘要
DNA/RNA甲基化在肺癌的发生和发展中起着重要作用。液体活检利用肿瘤细胞释放到体液中的细胞、核苷酸和蛋白质来辅助癌症的诊断和预后评估。循环肿瘤DNA（ctDNA）的甲基化作为肺癌的生物标志物越来越受到关注。在此，我们简要介绍ctDNA甲基化的生物学基础和检测方法，并综述甲基化DNA在肺癌筛查、诊断、预后、监测及治疗预测等体液检测中的各种应用。我们还讨论了RNA甲基化作为癌症生物标志物的新作用。
相似文献
1
Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer.
Biol Proced Online. 2017 Mar 17;19:2. doi: 10.1186/s12575-017-0051-8. eCollection 2017.
2
Methylation analyses in liquid biopsy.
Transl Lung Cancer Res. 2016 Oct;5(5):492-504. doi: 10.21037/tlcr.2016.10.03.
3
Applying circulating tumor DNA methylation in the diagnosis of lung cancer.
Precis Clin Med. 2019 Mar;2(1):45-56. doi: 10.1093/pcmedi/pbz003. Epub 2019 Mar 15.
4
Methylated circulating tumor DNA in blood: power in cancer prognosis and response.
Endocr Relat Cancer. 2016 Mar;23(3):R157-71. doi: 10.1530/ERC-15-0369. Epub 2016 Jan 13.
5
Liquid biopsy of circulating tumor DNA and biosensor applications.
Biosens Bioelectron. 2019 Feb 1;126:596-607. doi: 10.1016/j.bios.2018.11.037. Epub 2018 Nov 22.
6
Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA).
Micromachines (Basel). 2018 Feb 28;9(3):100. doi: 10.3390/mi9030100.
7
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
Oncotarget. 2016 Jul 26;7(30):48832-48841. doi: 10.18632/oncotarget.9453.
8
Blood-based biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
Clin Chim Acta. 2016 Apr 1;455:26-32. doi: 10.1016/j.cca.2016.01.016. Epub 2016 Jan 18.
9
Circulating tumor DNA - Current state of play and future perspectives.
Pharmacol Res. 2018 Oct;136:35-44. doi: 10.1016/j.phrs.2018.08.017. Epub 2018 Aug 22.
10
Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
J Surg Res. 2019 Apr;236:184-197. doi: 10.1016/j.jss.2018.11.029. Epub 2018 Dec 21.
引用本文的文献
1
Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine.
EPMA J. 2023 May 22;14(2):249-273. doi: 10.1007/s13167-023-00323-7. eCollection 2023 Jun.
2
The importance of mA topology in chicken embryo mRNA: a precise mapping of mA at the conserved chicken β-actin zipcode.
RNA. 2023 Jun;29(6):777-789. doi: 10.1261/rna.079615.123. Epub 2023 Feb 21.
3
Circulating Tumor DNA Methylation Biomarkers for Characterization and Determination of the Cancer Origin in Malignant Liver Tumors.
Cancers (Basel). 2023 Jan 30;15(3):859. doi: 10.3390/cancers15030859.
4
Magnetic detection of albuminuria using hematite nanorods synthesized via chemical hydrothermal method.
Iran J Basic Med Sci. 2021 Jul;24(7):962-968. doi: 10.22038/ijbms.2021.53918.12120.
5
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test.
Nat Commun. 2020 Jul 21;11(1):3475. doi: 10.1038/s41467-020-17316-z.
6
Emerging non-invasive detection methodologies for lung cancer.
Oncol Lett. 2020 May;19(5):3389-3399. doi: 10.3892/ol.2020.11460. Epub 2020 Mar 12.
7
Parallel serial assessment of somatic mutation and methylation profile from circulating tumor DNA predicts treatment response and impending disease progression in osimertinib-treated lung adenocarcinoma patients.
Transl Lung Cancer Res. 2019 Dec;8(6):1016-1028. doi: 10.21037/tlcr.2019.12.09.
8
Aberrant Methylation Status of Tumour Suppressor Genes in Ovarian Cancer Tissue and Paired Plasma Samples.
Int J Mol Sci. 2019 Aug 23;20(17):4119. doi: 10.3390/ijms20174119.
9
Functions of RNA N6-methyladenosine modification in cancer progression.
Mol Biol Rep. 2019 Apr;46(2):2567-2575. doi: 10.1007/s11033-019-04655-4. Epub 2019 Mar 25.
10
Functions of RNA N6-methyladenosine modification in cancer progression.
Mol Biol Rep. 2019 Feb;46(1):1383-1391. doi: 10.1007/s11033-018-4471-6. Epub 2019 Feb 20.
本文引用的文献
1
Dynamic alterations of bone marrow cytokine landscape of myelodysplastic syndromes patients treated with 5-azacytidine.
Oncoimmunology. 2016 May 13;5(10):e1183860. doi: 10.1080/2162402X.2016.1183860. eCollection 2016.
2
Establishment of two data mining models of lung cancer screening based on three gene promoter methylations combined with telomere damage.
Int J Biol Markers. 2017 Mar 2;32(1):e141-e146. doi: 10.5301/jbm.5000232.
3
DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk.
Int J Cancer. 2017 Jan 1;140(1):50-61. doi: 10.1002/ijc.30431. Epub 2016 Oct 11.
4
Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.
Oncotarget. 2016 Oct 4;7(40):64527-64542. doi: 10.18632/oncotarget.11743.
5
Hypomethylation of human-specific family of LINE-1 retrotransposons in circulating DNA of lung cancer patients.
Lung Cancer. 2016 Sep;99:127-30. doi: 10.1016/j.lungcan.2016.07.005. Epub 2016 Jul 5.
6
Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
J Thorac Oncol. 2017 Jan;12(1):77-84. doi: 10.1016/j.jtho.2016.08.123. Epub 2016 Aug 18.
7
Comparison and combination of blood DNA methylation at smoking-associated genes and at lung cancer-related genes in prediction of lung cancer mortality.
Int J Cancer. 2016 Dec 1;139(11):2482-92. doi: 10.1002/ijc.30374. Epub 2016 Aug 22.
8
Tobacco smoking and methylation of genes related to lung cancer development.
Oncotarget. 2016 Sep 13;7(37):59017-59028. doi: 10.18632/oncotarget.10007.
9
Epigenetic Determinants of Cancer.
Cold Spring Harb Perspect Biol. 2016 Sep 1;8(9):a019505. doi: 10.1101/cshperspect.a019505.
10
No association between global DNA methylation in peripheral blood and lung cancer risk in nonsmoking women: results from a multicenter study in Eastern and Central Europe.
Eur J Cancer Prev. 2018 Jan;27(1):1-5. doi: 10.1097/CEJ.0000000000000244.
Zotero 插件